Nufarm targets $380M earnings for FY26
- Nufarm projects FY26 underlying EBITDA between $370 million and $380 million, representing 25% growth at the midpoint.
- Leverage is expected to fall from 2.7 times to 2.0 times by September.
- The company is executing factory closures and product rationalisation to secure $50 million in run-rate cost savings by the end of FY27.
Agricultural chemical company Nufarm (ASX:NUF) expects its FY26 underlying EBITDA to reach between $370 million and $380 million.
The projected earnings represent an approximate 25% increase compared to the prior corresponding period, driven by growth in hybrid seeds and Omega-3 platforms.
Secondary operational details include plans to shut down its manufacturing facility in Alsip in the United States alongside the previously announced closure of its Kwinana site in Western Australia.
The company stated that disciplined working capital management and improved earnings will help reduce leverage to approximately 2.0 times by Sept. 30.
Following the announcement the Nufarm share price was unchanged at $3.20.
The business continues to execute a broader strategy refresh aimed at simplifying operations and lowering its total cost base.
Management confirmed that its ongoing SKU rationalisation initiatives keep the firm on track to deliver $50 million of run-rate cost savings by the end of FY27.
